-
Cosmeceuticals Global Market Report 2025| Business Growth, Development Factors, Current and Future Trends till 2029
24 Nov 2025 10:00 GMT
The Business Research Company’s Cosmeceuticals Global Market Report 2025 – Market Size, Trends, And Forecast 2025-2034
LONDON, GREATER LONDON, UNITED KINGDOM, November 24, 2025 /EINPresswire.com/ -- How Much Is The Cosmeceuticals Market Worth?
…
-
Zymeworks wanted to be Canada’s first Big Pharma. Despite two blockbusters-in-the-making, that’s no longer the plan
24 Nov 2025 10:14 GMT
Open this photo in gallery:Zymeworks CEO Kenneth Galbraith in Cambridge, England last Thursday.Betty Laura Zapata
Ali Tehrani had two goals when he founded antibody developer Zymeworks Inc. ZYME-Q: to develop drugs that would improve human health and to …
-
Anticonvulsants Market Size Worth $22.29 Billion by 2029 - Exclusive Report by The Business Research Company
24 Nov 2025 01:30 GMT
The Business Research Company’s Anticonvulsants Global Market Report 2025 – Market Size, Trends, And Forecast 2025-2034
LONDON, GREATER LONDON, UNITED KINGDOM, November 24, 2025 /EINPresswire.com/ -- How Much Is The Anticonvulsants Market Worth? …
-
Viscosupplementation Global Market Report 2025 | Business Growth, Development Factors, Current & Future Trends till 2029
24 Nov 2025 00:00 GMT
The Business Research Company's Viscosupplementation Global Market Report 2025 – Market Size, Trends, And Global Forecast 2025-2034
LONDON, GREATER LONDON, UNITED KINGDOM, November 24, 2025 /EINPresswire.com/ -- "Get 20% Off All Global …
-
Rx Rundown: Johnson & Johnson, Avadel Pharmaceuticals, Moderna and more
21 Nov 2025 12:26 GMT
Deals:
Abbott announced it is acquiring Exact Sciences for $21 billion.
Johnson & Johnson entered into a definitive agreement to acquire Halda Therapeutics OpCo for $3.05 billion in cash.
Eli Lilly announced it will pay $40 million upfront and up to $ …
-
Silexion Therapeutics Is Building a Tumor-Targeting Technology That’s Aligned With Big Pharma’s Billion-Dollar Priorities (NASDAQ: SLXN)
22 Nov 2025 19:49 GMT
NY (PinionNewswire) —
Oncology dealmaking has roared back, with big pharma spending billions to acquire therapies that can hit multiple hard-to-treat tumor types, introduce novel mechanisms, and scale quickly once early signals are validated. These …
-
Chronic Heart Failure Clinical Trial Pipeline Shows Potential with Active Contributions from 25+ Key Companies | DelveInsight
25 Nov 2025 18:00 GMT
New York, USA, Nov. 25, 2025 (GLOBE NEWSWIRE) -- Chronic Heart Failure Clinical Trial Pipeline Shows Potential with Active Contributions from 25+ Key Companies | DelveInsight Chronic heart failure (CHF) is a progressive condition where the heart is unable …
-
Refractive Surgery Council Expands Medical Editorial Advisory Board Supporting High-Quality Patient Education
25 Nov 2025 14:00 GMT
World-renowned Refractive Surgeons Work to Make Evidence-Based Vision Correction Information Available to Patients
DALLAS, TX, UNITED STATES, November 25, 2025 /EINPresswire.com/ -- The Refractive Surgery Council (RSC) today announced the …
-
Monoclonal Antibody for Asthma and COPD Market Towards USD 58.94 Billion by 2035
25 Nov 2025 13:00 GMT
Ottawa, Nov. 25, 2025 (GLOBE NEWSWIRE) -- The global monoclonal antibody for asthma and COPD market size is calculated at USD 35.94 billion in 2026 and is expected to reach around USD 58.94 billion by 2035, growing at a CAGR of 5.65% for the forecasted …
-
Sports Medicine Market Size, Share & Trends Analysis Report By Product
25 Nov 2025 06:14 GMT
The Business Research Company’s Sports Medicine Global Market Report 2025 - Market Size, Trends, And Global Forecast 2025-2034
LONDON, GREATER LONDON, UNITED KINGDOM, November 25, 2025 /EINPresswire.com/ -- Get 20% Off All Global Market Reports …
About
© 1995-2025